|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Ankur Drugs & Pharma Ltd.
Main Activities: Chemical Manufacturing - Health and Personal Care Stores
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Ankur Drugs & Pharma Ltd. Legal Address C-306, Crystal Plaza,, Andheri Link Road, Andheri (W); Mumbai; Maharashtra; 400053 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : INE238D01012 Financial Auditors: M.G. Vashi & Co. (2012) Incorporation Date: February 9, 1995 Total Employees: 1,850 Tel: 40682300 |
|
Company Description |
| Ankur Drugs and Pharma Limited engages in the contract manufacture of pharmaceutical formulations in various dosage forms in India. It offers various dosage forms, including tablets, capsules, liquid orals, oral powders, dry syrups, ointments, insta use suspension, FFS, liquid injectables, and dry powder injectables. The company was incorporated in 1995 and is based in Mumbai, India. |
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues decreased with -79.24%, from INR 829.42 tens of millions to INR 172.17 tens of millions. Operating Results decreased from INR 132.5 tens of millions to INR -29.83 tens of millions. The results of the period decreased -185.96% reaching INR -165.4 tens of millions at the end of the period against INR -57.84 tens of millions last year. Return on equity (Net income/Total equity) went from -20.05% to -0.64%, the Return On Asset (Net income / Total Asset) went from -3.88% to -16.24% and the Net Profit Margin (Net Income/Net Sales) went from -6.97% to -96.07% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 3.05% compared to 433.89% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 0.95 to 0.19 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2013 Q3C (non-cons) |
2013 H1 (non-cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| Dion Global Solutions - AsianCERC | Dion Global Solutions - AsianCERC | |
| ||
| Unit | Tens of Millions) | Tens of Millions |
| ||
Balance Sheet
| ||
Shareholders Equity |
19 |
19 |
| ||
| * All the accounts are in INR. | ||
Income Statement
| ||
Total Operating Revenue |
104 |
68 |
| ||
Operational Profit (Loss) |
-54 |
-36 |
| ||
Net Profit (Loss) |
-127 |
-86 |
| ||
| * All the accounts are in INR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Equity (ROE) |
-660.81% |
-449.64% |
| ||
Annualised Return on Equity (ROE) |
-881.08% |
-899.28% |
| ||
Return on Sales (ROS) |
100.19% |
100.2% |
| ||
 |